Levodopa treatment of Parkinson's syndrome: past and future
Pletscher, A.
Advances in Neurology 53: 469-473
1990
ISSN/ISBN: 0091-3952 PMID: 2239486 Document Number: 355287
Document emailed within 1 workday
Related Documents
Sigwald, J.; Chomette, G.; Raymondeaud, C. 1972: Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients La semaine des hopitaux: organe fonde par l'Association d'enseignement medical des hopitaux de Paris 48(9): 609-624Białecka, M.; Adamiak, U.; Gawrońska-Szklarz, B. 2009: Optimisation of treatment of Parkinson's disease with levodopa Neurologia i Neurochirurgia Polska 43(5): 446-459
Larsen, J.P.; Nessler, E.G.; Hestnes, A.; Vilming, S.; Holmsen, R.; Aksnes, V.; Johnson, S.; Brodtkorb, E.; Hunstad, N.A.; Helle, J.R. 1991: Treatment of Parkinson disease with levodopa depot preparations Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(26): 3163-3166
Sweet, R.D.; Lee, J.E.; McDowell, F. 1971: Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease Transactions of the American Neurological Association 96: 59-65
Stern, P.H.; McDowell, F.; Miller, J.M.; Robinson, M. 1970: Levodopa and physical therapy in treatment of patients with Parkinson's disease Archives of Physical Medicine and Rehabilitation 51(5): 273-277
Molina, J.A.; Jiménez-Jiménez, F.J.; Ortí-Pareja, M. 1999: Motor and mental complications in the long-term treatment of complicated Parkinson's disease with levodopa Revista de Neurologia 28(10): 982-990
Sage, J.I.; Trooskin, S.; Sonsalla, P.K.; Heikkila, R.E. 1989: Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease Neurology 39(11 Suppl 2: 60
Timofeeva, A.A. 2014: Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(11): 145-151
Goulley, F.; Wolmark, Y.; Bourdeix, I.; Chaumet-Riffaud, P.D. 1993: Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms Therapie 48(3): 233-238
Fernandez-Pajarin, G.; Ares-Pensado, B.; Sesar, A.; Iglesias-Canle, J.; Masa-Vazquez, L.; Castro, A. 2018: Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease Revista de Neurologia 67(1): 1-5
Fiszer, U. 1989: Study of the immunologic status of persons with Parkinson disease with special reference to the effect of levodopa treatment. Preliminary report Neurologia i Neurochirurgia Polska 23(1): 7-11
Aaltonen, H.; Kilkku, O.; Heinonen, E.; Mäki-Ikola, O. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality Bmj 317(7172): 1586-1587
Arai, M. 2012: Levodopa in combination with carbidopa does not affect plasma arginine vasopressin levels in treatment-naïve older patients with Parkinson's disease: a before-after study Neuro Endocrinology Letters 33(1): 34-36
Lökk, J. 2003: Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels Lakartidningen 100(35): 2674-2677
Vajda, F.J.; Donnan, G.A.; Bladin, P.F. 1978: Patterns of response to levodopa in Parkinson's disease Clinical and Experimental Neurology 15: 299-306
Rudakova, A.V.; Yakupov, E.Z. 2014: Pharmacoeconomic aspects of using levodopa/carbidopa intestinal gel in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10): 117-121
Houeto, J.L.; Mesnage, V.; Welter, M.L.; Mallet, L.; Agid, Y.; Bejjani, B.P. 2003: Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up Neurology 60(1): 154-5; Author Reply 154-5
Slaoui, T.; Mas-Gerdelat, A.; Ory-Magne, F.; Rascol, O.; Brefel-Courbon, C. 2007: Levodopa modifies pain thresholds in Parkinson's disease patients Revue Neurologique (Paris) 163(1): 66-71
Lee, S.T.; Lu, C.S. 1996: Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease Journal of the Formosan Medical Association 95(12): 943-945
Liashchenko, E.A.; Skripkina, N.A.; Levin, O.S. 2013: Influence of levodopa, stalevo on dyskinesia in Parkinson's disease: STRIDE-PD study Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(7 Part 2): 62-68